sepsis: management of maternal sepsis clinical guideline · sepsis during pregnancy and the...
TRANSCRIPT
Sepsis: Management of Maternal Sepsis Clinical Guideline
V2.3
June 2020
Sepsis: Management of Maternal Sepsis Clinical Guideline V2.3 Page 2 of 14
1. Aim/Purpose of this Guideline 1.1. To provide guidance for obstetricians, anaesthetists, midwives and nurses
enabling prompt diagnosis and management of sepsis in pregnant and postnatal women.
1.2. This version supersedes any previous versions of this document.
1.3. This guideline makes recommendations for women and people who are pregnant. For simplicity of language the guideline uses the term women throughout, but this should be taken to also include people who do not identify as women but who are pregnant, in labour and in the postnatal period. When discussing with a person who does not identify as a woman please ask them their preferred pronouns and then ensure this is clearly documented in their notes to inform all health care professionals (NEW 2020).
2. The Guidance 2.1. Introduction
2.1.1. Sepsis during pregnancy and the puerperium (i.e. until 6 weeks postnatally) remains the leading direct cause of maternal death in the UK (UKOSS, 2015) Sepsis is a medical emergency and the first hour of diagnosis is crucial in achieving a successful outcome. Each hour of delay in administering broad spectrum intravenous antibiotic is associated with a measurable increase in maternal mortality.
2.1.2. Sepsis is the body’s overwhelming and life threatening response to infection that can lead to tissue damage, organ failure and death
2.1.3. Signs of severe sepsis in peripartum women, particularly with group A streptococcal infection should be regarded as an obstetric emergency. Symptoms of sepsis may be less distinctive than in the non-pregnant population and are not necessarily present in all cases; therefore, a high index of suspicion is necessary. Bacteraemia can progress rapidly to severe sepsis.
Data Protection Act 2018 (General Data Protection Regulation – GDPR) Legislation
The Trust has a duty under the DPA18 to ensure that there is a valid legal basis to process personal and sensitive data. The legal basis for processing must be identified and documented before the processing begins. In many cases we may need consent; this must be explicit, informed and documented. We cannot rely on opt out, it must be opt in.
DPA18 is applicable to all staff; this includes those working as contractors and providers of services.
For more information about your obligations under the DPA18 please see the Information Use Framework Policy or contact the Information Governance Team [email protected]
Sepsis: Management of Maternal Sepsis Clinical Guideline V2.3 Page 3 of 14
2.1.4. All recently delivered women should be informed of the signs and symptoms of genital tract infection and how to prevent its transmission3.
2.2. Risk factors for maternal sepsis in pregnancy and the puerperium
Obesity
Impaired glucose tolerance/diabetes
Impaired immunity/immunosuppressant medication
Anaemia
Offensive Vaginal discharge
History of pelvic infection
History of group B streptococcal infection
Amniocentesis and other invasive procedures
Cervical cerclage
Prolonged spontaneous rupture of membranes
Vaginal trauma, caesarean section, wound hematoma
Retained products of conception
Group A streptococcus infection in close contacts/family members
Black or other minority ethnic group origin 2.3. Clinical symptoms suggestive of sepsis
Fever or rigors
Diarrhoea or vomiting Rash, generalized rash
Abdominal/pelvic pain and tenderness
Offensive vaginal discharge
Productive cough
Urinary symptoms
General – nonspecific signs such as lethargy, reduced appetite
Breast engorgement/redness
Wound infection,
Delay in uterine involution, heavy lochia (postnatally)
Impaired mental state
Genital tract sepsis may present with constant severe abdominal pain and tenderness unrelieved by simple oral analgesia. Severe infection may also be associated with pre term labour. Toxic shock syndrome caused by staphylococcal or streptococcal exotoxins can produce symptoms including diarrhoea, nausea and vomiting.
2.4. Clinical signs suggestive of sepsis Includes one or more of the
following:
Pyrexia (temp >38°C)
Hypothermia (temp <36°C)
Tachycardia (>100 bpm)
Tachypnoea, (>20 breaths per minute)
Hypoxia/requiring O2 to maintain SATS
Hypotension
Oliguria
New confusion
Fetal tachycardia/abnormal CTG particularly in the presence of meconium
Sepsis: Management of Maternal Sepsis Clinical Guideline V2.3 Page 4 of 14
Hyperglycemia, in absence of diabetes (Glucose >7mmol)
These signs, including pyrexia may not always be present and are not necessarily related to the severity of sepsis.
2.5. Recognition of sepsis
2.5.1. Recognition of Sepsis in the hospital setting 2.5.1.1. Maternity Early Obstetric Warning Scoring system (MEOWS)
is an essential tool for assessing a woman’s clinical condition. If infection is suspected, the named midwife must commence a MEOWS chart and fluid balance chart.
2.5.1.2. If MEOWS score is 5 or more complete the Sepsis Screening Tool (Appendix 3) and transfer to Delivery Suite and manage as per sepsis 6 BUFALO bundle (See appendix 4).
2.5.1.3. Review the patient within 30 minutes of admission to delivery
Suite. If the obstetric team are unavailable, it must be clearly documented in the notes why and when a review is expected. The co-ordinator should review the patient to assess the urgency. If a Dr is required urgently, immediate escalation to the Obstetric Consultant on call should take place. Until the review happens the co-ordinator should be kept up to date with any changes. (New 2019).
2.5.2. Midwives working from the community or Birth Centre’s
2.5.2.1. Community midwives request a category one ambulance, cannulate if competencies allow and administer IV fluids.
2.5.2.2. When ambulance arrives administer facial O2 to maintain SATS >94% and if IV fluids administered by midwife document in notes.
2.5.2.3. It is important to remember that some physiological
changes in labour such as raised heart rate are normal and may not be related to sepsis.
2.6. General Management of Sepsis
2.6.1. Complete and carry out BUFALO steps initiating broad spectrum antibiotics as per trust policy within the hour.
2.6.2. Consider paracetamol for women in labour with a fever, a temperature of 38°C or above (on a single reading) or 37.5°C or above on 2 consecutive readings (two hours apart). (NICE 2019)
2.6.3. Be aware that paracetamol is not a treatment for sepsis and should
not delay investigation if sepsis is suspected.
2.6.4. Avoid Ibuprofen
Sepsis: Management of Maternal Sepsis Clinical Guideline V2.3 Page 5 of 14
2.7. Management of Sepsis in Labour / suspected Chorioamnionitis 2.7.1. The risk of neonatal encephalopathy and cerebral palsy is increased in
the presence of intrauterine infection.
2.7.2. Undertake a multidisciplinary review by obstetrician, anaesthetist, senior midwife, labour ward coordinator, microbiologist.
2.7.3. Document a clear plan with regular review taking account of the clinical
picture and response to treatment (NICE 2019).
2.7.4. Involve the woman in decision making regarding mode of delivery (NICE 2019).
2.7.5. When considering mode and timing of delivery consider
Source and severity of sepsis
Gestation
Fetal wellbeing
stage and progress of labour
parity
response to treatment
2.7.6. If the woman has a genital tract infection, the birth should be expedited taking account of the above considerations (NICE 2019).
2.8. Change to continuous intrapartum fetal monitoring;
2.8.1. Undertake continuous CTG with ST analysis if sepsis is suspected or if the temperature is >38°C once or 37.5°C on two occasions 2 hours apart.
2.8.2. The obstetric team must review the woman within 30 minutes of
admission to delivery suite and documented in the notes. If the obstetric team are unavailable, it must be clearly documented in the notes why and when a review is expected. The co-ordinator should review the patient to assess the urgency. If an obstetric review is required urgently, immediate escalation to the Obstetric Consultant on call should take place. Until the review happens the co-ordinator should be kept up to date with any changes (NEW 2020).
2.8.3. All women who are assessed as high risk must be reviewed by an
obstetrician a minimum of 6 hourly and this must be documented by them in the notes. If this timeframe cannot the reason why must be documented in the notes and the coordinator informed. (NEW 2020).
2.9. Aim for Vaginal delivery if;
Normal CTG
No significant ST events
making adequate progress
If using STAN then interpretation must be upgraded e.g if patient is being treated for sepsis and the CTG is classified as intermediary it would be upgraded to abnormal and ST events interpreted accordingly
Be aware that FBS can be falsely reassuring in the presence of sepsis
Sepsis: Management of Maternal Sepsis Clinical Guideline V2.3 Page 6 of 14
2.10. Analgesia in labour for women with sepsis 2.10.1. For women in labour needing antibiotics start antibiotics before
inserting needle for regional analgesia (NICE 2019).
2.10.2. Any concerns about providing a women’s choice of regional analgesia should be discussed with the anaesthetic consultant on call.
2.11. Post Natal
Ensure ongoing Multi-Disciplinary Team (MDT) review for first 24 hours. 2.12. Deteriorating Septic Patient
2.12.1. In severe or rapidly deteriorating cases including hypotension and/or a serum lactate >4mmol/l and where there is sign of end organ dysfunction.
Registrar needs to be in immediate attendance
On call Anaesthetic Registrar needs to be in immediate attendance
The on-call Consultant Obstetrician, Consultant Obstetric Anesthetist (ITU Consultant for out of hours) should be involved
Refer the woman to the HDU outreach team
Advice from the Consultant Microbiologist should be urgently sought.
2.12.2. Critical care outreach team and senior intensivist should be informed if has any sign of organ dysfunction
Altered consciousness
Hypotension
Decreased urine output
Reduced urine output – not responding to treatment
Need for 40% oxygen to maintain oxygen saturations to above 92%
Temperature less than 36 °C
2.12.3. Patient will be transferred to ITU/HDU if deemed appropriate and after MDT discussion.
2.12.4. Accurate record keeping is essential both in the written notes and on E3.
2.13. Sources of sepsis in the puerperium to be considered
All women who are unwell in the puerperium should be assessed clinically, and admission considered. Women may present with sepsis which is not deriving from the genital tract. Including:
Mastitis
UTI
Pneumonia
Gastroenteritis
Pharyngitis /sore throat- Group A strep
Infection related to regional anaesthetic
Infective endocarditis
Retained tissue
Sepsis: Management of Maternal Sepsis Clinical Guideline V2.3 Page 7 of 14
3. Monitoring compliance and effectiveness Element to be monitored
Implementation of new Sepsis Screening Tool
The use of sepsis 6 BUFALO
Were IV ABX administered within 1 hour of identification
Lead Audit Midwives
Tool Sepsis audit at per trust ongoing audit undertaken by audit midwives
Frequency As per trust sepsis audit
Reporting arrangements
Maternity Patient Safety Forum
Acting on recommendations and Lead(s)
Any deficiencies identified will be discussed at patient safety meeting or maternity forum. Action leads will be identified and a time frame set for the action to be completed. The action plan will be monitored by the maternity Patient safety forum
Change in practice and lessons to be shared
Required changes to practice will be identified and actioned within 3 months. A lead member of the team will be identified to take each change forward where appropriate. Lessons will be shared with all the relevant stakeholders
4. Equality and Diversity
4.1. This document complies with the Royal Cornwall Hospitals NHS Trust service Equality and Diversity statement which can be found in the or the Equality and Diversity website.
4.2. Equality Impact Assessment The Initial Equality Impact Assessment Screening Form is at Appendix 2.
Sepsis: Management of Maternal Sepsis Clinical Guideline V2.3 Page 8 of 14
Appendix 1. Governance Information
Document Title Sepsis: Management of Maternal Sepsis Clinical Guideline V2.3
This document replaces (exact title of previous version):
Sepsis: Management of Maternal Sepsis Clinical Guideline V2.2
Date Issued/Approved: May 2020
Date Valid From: June 2020
Date Valid To: May 2022
Directorate / Department responsible (author/owner):
Sophie Haynes, Obstetric Consultant
Contact details: 01872 250000
Brief summary of contents
Guidance for obstetricians, anaesthetists, midwives and nurses to enable prompt diagnosis and management of sepsis in antenatal and postnatal women.
Suggested Keywords: Sepsis, infection, MEOWS
Target Audience RCHT CFT KCCG
Executive Director responsible for Policy:
Medical Director
Approval route for consultation and ratification:
Maternity Guidelines Group Obs and Gynae Directorate Meeting Divisional Board
General Manager confirming approval processes
Debra Shields, Care Group Manager
Name of Governance Lead confirming approval by specialty and care group management meetings
Caroline Amukusana
Links to key external standards None required
Related Documents:
NICE Intrapartum care for women with existing medical conditions or obstetric complications and their babies NG121 (2019)
Severe maternal Sepsis UKOSS (2015)
The UK sepsis Trust professional resources
RCOG Green Top Guideline No. 64A
NICE recognition diagnosis and early management (2016)
CMACE (2008) Saving Mothers’ Lives: Reviewing maternal deaths to make
Sepsis: Management of Maternal Sepsis Clinical Guideline V2.3 Page 9 of 14
motherhood safer: 2006–2008
Surviving Sepsis (2012) International Guidelines for Management of Severe Sepsis and Septic Shock
Training Need Identified? No
Publication Location (refer to Policy on Policies – Approvals and Ratification):
Internet & Intranet Intranet Only
Document Library Folder/Sub Folder
Clinical / Midwifery and Obstetrics
Version Control Table
Date Version
No Summary of Changes
Changes Made by (Name and Job
Title) 2nd October 2014
V1.0 Initial Review Louise Forster Obstetric Registrar
20th May 2016
V1.1 Bufalo sticker appendix added
Sarah-Jane Pedler Practice Development Midwife
4th August 2016
V1.2 Lactate amended to >2 in line with RCHT sepsis guideline
Sarah-Jane Pedler Practice Development Midwife
2nd May 2019
V2.0
Reviewed, benchmarked and updated with up to date guidance and sepsis tool updated to reflect PROMPT training, the guideline and MEOWS trigger
Sophie Haynes Consultant Obstetrician Sarah-Jane Pedler Practice Development Midwife
12th June 2019
V2.1 Change to the watermark in Appendix 3
Sarah-Jane Pedler Practice Development Midwife
August 2019
V2.2
Additions to the guideline following Health Service Investigation Branch (HSIB) regarding escalation to the Obstetrician
Sarah-Jane Pedler, Practice Development Midwife
May 2020 V2.3
Addition of 1.4. inclusion statements Addition of Obstetric review times (30 minutes and 6 hourly ongoing) 2.8.2. 2.8.3.
Julie Walton Audit Midwife
Sepsis: Management of Maternal Sepsis Clinical Guideline V2.3 Page 10 of 14
All or part of this document can be released under the Freedom of Information Act 2000
This document is to be retained for 10 years from the date of expiry.
This document is only valid on the day of printing
Controlled Document This document has been created following the Royal Cornwall Hospitals NHS Trust Policy for the Development and Management of Knowledge, Procedural and Web Documents (The Policy on Policies). It should not be altered in any way without the express permission of the author or their Line Manager.
Sepsis: Management of Maternal Sepsis Clinical Guideline V2.3 Page 11 of 14
Appendix 2. Equality Impact Assessment
Section 1: Equality Impact Assessment Form
Name of the strategy / policy /proposal / service function to be assessed Sepsis: Management of Maternal Sepsis Clinical Guideline V2.3
Directorate and service area: Obstetrics and Gynaecology
Is this a new or existing Policy? Existing
Name of individual/group completing EIA Sophie Haynes, Obstetric Consultant
Contact details: 01872 250000
1. Policy Aim Who is the strategy / policy / proposal / service function aimed at?
All staff who care for women in the obstetric setting
2. Policy Objectives To support all staff and those in their care who develop sepsis.
3. Policy Intended Outcomes To ensure that there is clear guidance to follow if a patient becomes
septic.
4. How will you measure the outcome?
Using the monitoring compliance tool
5. Who is intended to benefit from the policy?
All pregnant women who become septic
6a). Who did you consult with?
b). Please list any groups who have been consulted about this procedure.
Workforce Patients Local groups
External organisations
Other
X
Please record specific names of groups:
Maternity Guidelines Group Obstetrics and Gynaecology Directorate
c). What was the outcome of the consultation?
Guideline agreed
Sepsis: Management of Maternal Sepsis Clinical Guideline V2.3 Page 12 of 14
7. The Impact Please complete the following table. If you are unsure/don’t know if there is a negative impact you need to repeat the consultation step. Are there concerns that the policy could have a positive/negative impact on:
Protected Characteristic
Yes No Unsure Rationale for Assessment / Existing Evidence
Age X
Sex (male, female non-binary, asexual etc.)
X
Gender reassignment X
Race/ethnic communities /groups
X
Disability (learning disability, physical disability, sensory impairment, mental health problems and some long term health conditions)
X
Religion/ other beliefs X
Marriage and civil partnership X
Pregnancy and maternity X
Sexual orientation (bisexual, gay,
heterosexual, lesbian) X
If all characteristics are ticked ‘no’, and this is not a major working or service change, you can end the assessment here as long as you have a robust rationale in place.
I am confident that section 2 of this EIA does not need completing as there are no highlighted risks of negative impact occurring because of this policy.
Name of person confirming result of initial impact assessment:
Sophie Haynes, Obstetric Consultant
If you have ticked ‘yes’ to any characteristic above OR this is a major working or service change, you will need to complete section 2 of the EIA form available here: Section 2. Full Equality Analysis For guidance please refer to the Equality Impact Assessments Policy (available from the document library) or contact the Human Rights, Equality and Inclusion Lead [email protected]
Sepsis: Management of Maternal Sepsis Clinical Guideline V2.3 Page 13 of 14
Appendix 3. Maternal Sepsis Screening Tool
Maternal Sepsis Screening Tool
☐Respiratory rate ≥ 25
☐SpO2 < 92% without O2
☐Heart rate > 130
☐Systolic BP ≤ 90
☐Altered mental status/
responds only to voice, pain or
unresponsive
☐Blood Lactate ≥ 2.0*
☐Non-blanching
rash/mottled/cyanotic
☐Urine < 0.5 mL/kg/hr
☐No urine for 18 hours*Lactate measurement may be transiently elevated during and
immediately after normal labour and birth. If unsure, repeat sample
1. Has MOEWS been triggered?
2. Does the woman look sick?
3. Is the fetal heart rate ≥ 160 bpm?
4. Could this woman have an infection?
☐Respiratory rate 21-24
☐Heart rate 100-130
☐Systolic BP 91-100
☐ 1x Temperature <36 or >38°C
☐ 2x temperatures >37.5°C at
least two hours apart
☐No urine output for 12-18
hours
☐Abnormal CTG or significant
rise e.g. > 20bpm above baseline
☐Prolonged ruptured
membranes
☐Recent invasive procedure
☐Bleeding/wound
infection/offensive vaginal
discharge/abdominal or uterine
pain
☐Contact with Group A Strep
☐Change in mental state
☐Diabetes/gestational
diabetes/immunosuppressed
☐Respiratory rate ≤ 20
☐Heart rate < 100
☐Systolic BP > 100
☐Normal mental status
☐ Temperature 36-37.4°C
☐ Looks well
☐Normal CTG
☐Normal urine output
Completed by:
Name: Designation: Time:
Signature: Date:
Patient ID
Common infections include:
• Chorioamnionitis/endometritis
• Urinary tract infection
• Wound infection
• Influenza/pneumonia
• Mastitis/breast abscess
High risk criteria Moderate risk criteria Low risk criteria
If ONE criterion is present:
Commence 'Sepsis Six' NOW
Immediate obstetric review
(middle grade or above)
Transfer to Obstetric Unit if in the
community
Inform Consultant Obstetrician
& Consultant Anaesthetist
Commence MEOWS chart
Commence BUFALO sticker
If TWO criteria are present:
Also consider if only ONE criterion
Send bloodsFBC, lactate, CRP, U+Es, LFTs
Obstetric review (ST3 or
higher) within one hour
Consider ‘Sepsis Six’ or
commencing antibiotics if
infection but not septic
If ALL criteria are present:
LOW RISK OF SEPSIS
Review and monitor for
improvement or deterioration
and continue MEOWS
observations
Consider obstetric need and
full clinical picture
If YES to any of the above, complete the risk assessment
Review bloods
If lactate > 2, persistent raised
temperature or CTG changes, or
Acute Kidney Injury present
follow
HIGH RISK / BUFALO
Sepsis: Management of Maternal Sepsis Clinical Guideline V2.3 Page 14 of 14
Appendix 4: ‘Sepsis 6 (BUFALO) Care Pathway To be completed within 1 hour of admission if sepsis is suspected
Date:.................. Time:................
Staff Name:……………………. Designation:……………. Ward:…………..
Sepsis / Severe Sepsis Screening Tool
Sepsis / Severe Sepsis Screening Tool
U - Measure hourly Urine Output
Catheter if unconscious or retention, otherwise start strict fluid input chart.
F- Give a fluid challenge
Hypotensive: Syst BP< 90: STAT 20ml/kg Hartmann’s or 0.9% Saline, contact senior immediately. Normotensive: At least 500ml Hartmann’s or 0.9% Saline
Time Initial Reason not done or result
Time Initial Reason not done or result
Time Initial Reason not done or result
L- Measure lactate(blood gas: ED, ITU)
If > 2mmol/l: CONTACT Anaesthetist on call, give 20ml/kg Hartmann’s or 0.9% Saline FBC,LFT,U& E, Coag,Glucose.
B -Take blood cultures if not already taken
Consider sputum, MSU, HVS, MRSA & throat swab
0- Give high-flow oxygen
15l/minute via reservoir facemask initially. Monitor SATS.Seek expert help if used for > 4hr
A- Give IV antibiotics
Take blood cultures first According to Trust protocol (from intranet), 48 hour review at latest.
BP Syst < 90 / Mean < 65 (after initial fluid challenge)
Urine output < 0.5 ml/kg/hr for 2 hrs
INR > 1.5
aPTT > 60 s
Bilirubin > 34 μmol/l
O2 Needed to keep SpO2 > 90%
Platelets < 100 x 10
9/l
Creatinine > 177 μmol/l
Risk of neutropenic sepsis
This is SEVERE SEPSIS
Call Registrar or Consultant to attend within 30 mins,
document sepsis and action plan in notes.
Inform on call Anaesthetist, Critical Care Outreach Team
to attend urgently
Continue MEOWS every 30 mins. Reassess for high-risk factors each time condition
changes
Evaluation at 1 hour: MEOWS: Fluid volume given: Antibiotics: SHO: Inform Registrar (SBAR): situation= ‘Confirm Sepsis’, Liaise with Microbiologist on call
NO YES
Time Initial Reason not done or result
Time Initial Reason not done or result
Time Initial Reason not done or result
Patient Label